Home Teva's Generic Version of Xeloda Gains FDA Approval For Metastatic Colorectal And Breast Cancers
 

Keywords :   


Teva's Generic Version of Xeloda Gains FDA Approval For Metastatic Colorectal And Breast Cancers

2013-09-17 08:07:34| Biotech - Topix.net

The FDA granted approval to a generic version of Xeloda, produced by Teva Pharmaceutical, for the treatment of metastatic colorectal and breast cancers.

Tags: version approval generic gains

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.06Royal Mail buyer to make offer for all staff shares
25.06Hybrid Software wins FLAG Vendor Partner of the Year award
25.06Hospeco Purchases Nuance Solutions
25.06Atlantic Tropical Weather Outlook
25.06DNA Genetics opens new commercial sow research farm
25.06Eastern North Pacific Tropical Weather Outlook
25.06Briolf Group to Invest $30 Million in Its First US Production Plant
25.06IDENTCO rebrands TTL200 Series to DuraWrap and DuraFlag
More »